Association of Helicobacter pylori infection with gastric carcinoma:: A meta-analysis

被引:55
作者
Eslick, GD
Lim, LLY
Byles, JE
Xia, HHX
Talley, NJ
机构
[1] Univ Sydney, Nepean Hosp, Dept Med, Penrith, NSW 2751, Australia
[2] Univ Newcastle, Royal Newcastle Hosp, Ctr Clin Epidemiol & Biostat, Newcastle, NSW 2308, Australia
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVE: As conflicting studies have recently been published, we aimed to determine if Helicobacter pylori (H. pylori) infection is associated with gastric adenocarcinoma. METHODS: This was a meta-analysis of observational epidemiological studies. RESULTS: A total of 42 studies met the selection criteria and were categorized by the type of study design: eight cohort and 34 case-control studies. The pooled odds ratio for H. pylori in relation to gastric carcinoma was 2.04 (95% CI: 1.69-2.45). Both patient age (OR 0.77, 95% CI: 0.68-0.89) and intestinal type cancers (OR 1.14, 95% CI: 1.05-1.25) were independent effect modifiers. Analysis of other effect modifiers showed no relationship with female gender (OR 0.76, 95% CI: 0.64-0.89), stage of cancer (advanced %) (OR 1.12, 95% CI: 0.88-1.43), anatomical location (cardia %) (OR 1.54, 95% CI: 0.32-7.39) or cohort (nested case-control) studies (OR 1.72, 95% CI: 0.32-9.17). There was significant heterogeneity among the studies (tau(2) = 149; p < 0.001). The quality of the studies varied considerably, with the majority of excellent studies producing positive results and the very poor to moderate studies producing mixed results. CONCLUSIONS: H. pylori infection is associated with a 2-fold increased risk of developing gastric adenocarcinoma. (Am J Gastroenterol 1999;94:2373-2379. (C) 1999 by Am. Cell. of Gastroenterology).
引用
收藏
页码:2373 / 2379
页数:7
相关论文
共 79 条
[1]
ARCHIMANDRITIS A, 1993, ITAL J GASTROENTEROL, V25, P368
[2]
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer [J].
Aromaa, A ;
Kosunen, TU ;
Knekt, P ;
Maatela, J ;
Teppo, L ;
Heinonen, OP ;
Harkonen, M ;
Hakama, MK .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1996, 144 (02) :142-149
[3]
ASAKA M, 1994, CANCER, V73, P2691, DOI 10.1002/1097-0142(19940601)73:11<2691::AID-CNCR2820731107>3.0.CO
[4]
2-2
[5]
ASAKA M, 1995, EUR J GASTROEN HEPAT, V7, pS7
[6]
CONTRIBUTION OF HLA-DQA GENE TO HOSTS RESPONSE AGAINST HELICOBACTER-PYLORI [J].
AZUMA, T ;
KONISHI, J ;
TANAKA, Y ;
HIRAI, M ;
ITO, S ;
KATO, T ;
KOHLI, Y .
LANCET, 1994, 343 (8896) :542-543
[7]
Azuma T, 1998, CANCER, V82, P1013, DOI 10.1002/(SICI)1097-0142(19980315)82:6<1013::AID-CNCR2>3.0.CO
[8]
2-F
[9]
HELICOBACTER-PYLORI - COMPARISON OF DNA FINGERPRINTS PROVIDES EVIDENCE FOR INTRAFAMILIAL INFECTION [J].
BAMFORD, KB ;
BICKLEY, J ;
COLLINS, JSA ;
JOHNSTON, BT ;
POTTS, S ;
BOSTON, V ;
OWEN, RJ ;
SLOAN, JM .
GUT, 1993, 34 (10) :1348-1350
[10]
Analysis of Helicobacter pylori vacA and cagA genotypes and serum antibody profile in benign and malignant gastroduodenal diseases [J].
Basso, D ;
Navaglia, F ;
Brigato, L ;
Piva, MG ;
Toma, A ;
Greco, E ;
Di Mario, F ;
Galeotti, F ;
Roveroni, G ;
Corsini, A ;
Plebani, M .
GUT, 1998, 43 (02) :182-186